Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
about
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurityIntravitreal bevacizumab in retinopathy of prematurity: an interventional case series.Capillary-free vascularized retina in patients with aggressive posterior retinopathy of prematurity and late retinal capillary formationIntravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity.Preliminary anatomical and neurodevelopmental outcomes of intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity.Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective AnalysisMacular Development in Aggressive Posterior Retinopathy of Prematurity.Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurityRegression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis.Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity.Bedside Diode Laser Photocoagulation Under Remifentanil Analgesia for Retinopathy of Prematurity: Early Structural Outcomes.Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage.Characteristic clinical features associated with aggressive posterior retinopathy of prematurity.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Need for Refinement of International Retinopathy of Prematurity Guidelines and Classifications.Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment.Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity.Fluorescein angiography and retinal vascular development in premature infants.
P2860
Q24609568-4EFDC8B4-3289-42C3-8082-1988ECCCF127Q33873875-FFF47521-1E80-4F53-8764-DBD51986BF6AQ34642841-FD37BEF9-7316-4462-816C-4852FF467630Q34957565-EC2111B7-88D4-48B8-B806-A014DF979461Q35065062-D2FE02E7-2E83-4A3B-8D05-96AB173164B4Q35207113-3C65069C-8F92-4EBA-AABF-6E08B49FD3AAQ35553854-302BE744-03DC-4F4F-A2AF-D41B877A3E45Q35689258-55EA0B9F-5749-4D01-861C-18BC65A08709Q35851949-5510EC19-CED2-469D-BB45-EACC1809D2BCQ35984783-EC09C99D-C532-4F18-85E3-9664303421ABQ36145038-C10B5CA5-2FE2-4573-96B0-C8304055D395Q36241653-0BED5823-8AE2-4E88-BED6-CE7FC620A5B9Q36245132-BEA20915-F1C2-446D-B94F-AAAB5239FFC4Q36289348-36662E21-E04A-48A6-BB2B-43E71BFF0BACQ37627442-15A33CD9-3FB0-4326-8F43-D5496AECCAB4Q39085935-8482A20B-C596-4513-B7EE-9422A63101EBQ41703530-48D04983-8FF1-4ABC-959A-970B95798C6DQ45974194-3566895D-08A9-44AC-BFC9-F380C5CC64B9Q49362470-1F58F120-B499-435A-AB06-DABDFF925B76Q50794588-0AF444AD-0A91-453E-97CB-833EBE916A0E
P2860
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@ast
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@en
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@nl
type
label
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@ast
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@en
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@nl
prefLabel
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@ast
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@en
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@nl
P2093
P1433
P1476
Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
@en
P2093
Andres Kychenthal
Paola Dorta
Ximena Katz
P356
10.1097/01.IAE.0000244285.79004.E6
P433
P577
2006-09-01T00:00:00Z